These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24624911)

  • 21. Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia.
    Escherich G; Richards S; Stork LC; Vora AJ;
    Leukemia; 2011 Jun; 25(6):953-9. PubMed ID: 21372841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy.
    Adam de Beaumais T; Fakhoury M; Medard Y; Azougagh S; Zhang D; Yakouben K; Jacqz-Aigrain E
    Br J Clin Pharmacol; 2011 Apr; 71(4):575-84. PubMed ID: 21395650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia.
    Wahlund M; Nilsson A; Kahlin AZ; Broliden K; Myrberg IH; Appell ML; Berggren A
    J Pediatr; 2020 Jan; 216():150-157.e1. PubMed ID: 31635813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
    Nielsen SN; Toksvang LN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Appell ML; Hjalgrim LL; Schmiegelow K
    Cancer Chemother Pharmacol; 2021 Aug; 88(2):271-279. PubMed ID: 33928426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon.
    Zgheib NK; Akika R; Mahfouz R; Aridi CA; Ghanem KM; Saab R; Abboud MR; Tarek N; El Solh H; Muwakkit SA
    Pediatr Blood Cancer; 2017 Jan; 64(1):146-150. PubMed ID: 27577869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.
    Moriyama T; Nishii R; Perez-Andreu V; Yang W; Klussmann FA; Zhao X; Lin TN; Hoshitsuki K; Nersting J; Kihira K; Hofmann U; Komada Y; Kato M; McCorkle R; Li L; Koh K; Najera CR; Kham SK; Isobe T; Chen Z; Chiew EK; Bhojwani D; Jeffries C; Lu Y; Schwab M; Inaba H; Pui CH; Relling MV; Manabe A; Hori H; Schmiegelow K; Yeoh AE; Evans WE; Yang JJ
    Nat Genet; 2016 Apr; 48(4):367-73. PubMed ID: 26878724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPLC determination of thiopurine nucleosides and nucleotides in vivo in lymphoblasts following mercaptopurine therapy.
    Dervieux T; Chu Y; Su Y; Pui CH; Evans WE; Relling MV
    Clin Chem; 2002 Jan; 48(1):61-8. PubMed ID: 11751539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia.
    Larsen RH; Utke Rank C; Grell K; Nørgaard Møller L; Malthe Overgaard U; Kampmann P; Nersting J; Degn M; Nygaard Nielsen S; Holst H; Klug Albertsen B; Skov Wehner P; Thude Callesen M; Kanerva J; Leth Frandsen T; Als-Nielsen B; Lyngsie Hjalgrim L; Schmiegelow K
    Haematologica; 2021 Nov; 106(11):2824-2833. PubMed ID: 34047177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The development of an objective methodology to measure medication adherence to oral thiopurines in paediatric patients with acute lymphoblastic leukaemia--an exploratory study.
    Hawwa AF; Millership JS; Collier PS; McCarthy A; Dempsey S; Cairns C; McElnay JC
    Eur J Clin Pharmacol; 2009 Nov; 65(11):1105-12. PubMed ID: 19636546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia.
    Adam de Beaumais T; Jacqz-Aigrain E
    Eur J Clin Pharmacol; 2012 Sep; 68(9):1233-42. PubMed ID: 22421815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiopurine methyl transferase: activity and genotyping in patients with acute lymphoblastic leukemia.
    Brouwer C; Keizer-Garritsen JJ; Lambooy LH; Ament K; Ter Riet PG; De Abreu RA; Bökkerink JP; Van Wering ER; Van Der Does-Van Den Berg A; Veerman AJ; Trijbels JP
    Adv Exp Med Biol; 2000; 486():327-31. PubMed ID: 11783509
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia.
    Moriyama T; Nishii R; Lin TN; Kihira K; Toyoda H; Jacob N; Kato M; Koh K; Inaba H; Manabe A; Schmiegelow K; Yang JJ; Hori H
    Pharmacogenet Genomics; 2017 Jun; 27(6):236-239. PubMed ID: 28445187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
    Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
    Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of ITPA gene polymorphisms in Iranian patients with acute lymphoblastic leukemia and prediction of its myelosuppressive effects.
    Azimi F; Mortazavi Y; Alavi S; Khalili M; Ramazani A
    Leuk Res; 2015 Oct; 39(10):1048-54. PubMed ID: 26242828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiopurine treatment in childhood leukemia. Metabolic aspects and sensitivity.
    De Abreu RA; Bokkerink JP; Keuzenkamp-Jansen CW; Stet EH; Trijbels JF
    Adv Exp Med Biol; 1998; 431():687-92. PubMed ID: 9598153
    [No Abstract]   [Full Text] [Related]  

  • 36. PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity.
    Stocco G; Yang W; Crews KR; Thierfelder WE; Decorti G; Londero M; Franca R; Rabusin M; Valsecchi MG; Pei D; Cheng C; Paugh SW; Ramsey LB; Diouf B; McCorkle JR; Jones TS; Pui CH; Relling MV; Evans WE
    Hum Mol Genet; 2012 Nov; 21(21):4793-804. PubMed ID: 22846425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.
    Peregud-Pogorzelski J; Tetera-Rudnicka E; Kurzawski M; Brodkiewicz A; Adrianowska N; Mlynarski W; Januszkiewicz D; Drozdzik M
    Pediatr Blood Cancer; 2011 Oct; 57(4):578-82. PubMed ID: 21319286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thioguanine versus mercaptopurine in childhood ALL.
    Stanulla M; Schünemann HJ
    Lancet; 2006 Oct; 368(9544):1304-6. PubMed ID: 17046444
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical Application of Thiopurine Pharmacogenomics in Pediatrics.
    Pavlovic S; Kotur N; Stankovic B; Gasic V; Lucafo M; Decorti G; Zukic B
    Curr Drug Metab; 2020; 21(1):53-62. PubMed ID: 32124692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines.
    Niu N; Qin Y; Fridley BL; Hou J; Kalari KR; Zhu M; Wu TY; Jenkins GD; Batzler A; Wang L
    Genome Res; 2010 Nov; 20(11):1482-92. PubMed ID: 20923822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.